Nigerian drug distribution startup, DrugStoc raises $4.4m to expand its operations


DrugStoc, a Nigerian health-tech startup, has secured $4.4m in a Series A funding round to scale its efforts in Nigeria. The company was a beneficiary of the inaugural $1million Africa Netpreneur Prize Initiative by the Jack Ma Foundation in 2019 in which it received $65,000.

It was also a recipient of a grant from Bill and Melinda Gates and also received seed funding from VestedWorld; both of undisclosed amounts.

The Series A funding round was led by Africa HealthCare Master Fund (AAIC) with participation from Vested World, a repeat investor and the German Development Bank (DEG). Other private individuals also contributed to the round.

Launched in 2017, DrugStoc was founded by Chibuzor Opara and Adham Yehia. the healthtech startup is a procurement platform to source all the medications, consumables, and small medical devices needed for medical practices.

Drugstoc cofounders

Africa HealthCare Master Fund (AAIC) director, Nobuhiko Ichimiya expressed excitement at the investment.

“We are very excited to be part of the DrugStoc journey. The pharmaceutical market in Africa has enormous growth potential, and we are glad to back a company that is well positioned to be a key player in the sector’s growth in sub-saharan Africa,”

AAIC director, Nobuhiko Ichimiya.

DrugStoc’s co-founder and CEO, Chibuzor Opara, while expressing the company’s commitment to making an impact in the healthcare industry, said the funding will enable the startup to expand and launch its tech-enabled products in more African countries where pharmaceuticals are critically needed.

Connecting manufacturers with distributors

DrugStoc was borne out of IntegraHealth, a hospital management company founded by Opara and Yehia. The founders said they saw the gaps in the supply chain of the pharmaceutical industry in Nigeria and decided to fill them.

The duo then proceeded to launch a tech based platform to connect pharmaceutical manufacturers with distributors. In 2017, after a year-long incubation at Stanford’s Institute for Innovation in Developing Economies, they officially launched DrugStoc.

Instead of simply connecting manufacturers with distributors, the startup buys directly from the manufacturers and now distributes to hospitals and pharmacies. They also have a channel that helps pharmacies scale their businesses with collateral-free loans.

DrugStoc currently links 400 manufacturers to 3,200 doctors, hospitals and pharmacies. The startup earns a commission for every sale it makes and so far has a record of over 9 million prescriptions of their products dispensed.

According to the CEO, the platform’s monthly revenues have grown over 1,500% in the last three years. This, he says, can be attributed to the anti-counterfeit assurance that comes with their products.

Meeting the pharmaceutical needs of 100m Nigerians

CcHub's Growth Capital Fund announces investment in DrugStoc - Innovation  Village | Technology, Product Reviews, Business

With the new investment, DrugStoc plans to deliver quality pharmaceutical products to 100 million people within Nigeria, an exponential increase from the 14million they currently serve.

The plan includes expansion into 16 Nigerian states outside Lagos, more fulfilment centres as well as expanded transit points and routes. It also wants to provide better logistic options for last mile deliveries.

Furthermore, DrugStoc says it is building partnerships with financial institutions to increase access to sustainable supply chain financing. This is in addition to plans of more investments in cold chain infrastructure to enhance the safe distribution of perishable products.

DrugStoc also plans to expand its operations beyond Nigeria.

“In Nigeria, we intend to expand beyond 14 million we currently serve to cover just around 100 million people. And this would be achieved by expanding to about 16 states. Once we are done with the heavy lifting from that expansion, we will be training our sights on other countries.”

With Africa’s pharmaceutical industry set to be worth $70 billion by 2030, the healthtech startup will now double down on its vision to change the way healthcare providers interface with the pharmaceutical market and revolutionize sub-Saharan Africa’s access to quality pharmaceuticals. 

Now that you’re here, don’t forget to register to be a part of the largest crypto conference in Africa put together by Technext. Follow this link for registration and more info.

Technext Newsletter

Get the best of Africa’s daily tech to your inbox – first thing every morning.
Join the community now!

Technext Newsletter

Get the best of Africa’s daily tech to your inbox – first thing every morning.
Join the community now!